The Ontario Drug Benefit (ODB) is expanding the use of biosimilars starting on March 31, 2023. This means that patients who were covered by certain biologics such as Humira® will have coverage switched to a biosimilar.

This is a great time for patients to get more information about what a biosimilar is and how it compares to a biologic.

Biosimilars are similar to brand-name biologic drugs but are typically less expensive. If you're a Canadian patient interested in switching to a biosimilar, the first person you should talk to is your pharmacist.

Here's what you need to know about biosimilars and how to have a productive conversation with your pharmacist about them.

What are Biosimilars?

Biosimilars are biologic medications that are similar to brand-name biologics but are not identical copies. These drugs have been rigorously tested to ensure they are just as safe and effective as the original drugs, and they are approved by Health Canada. They are typically less expensive than the brand-name drugs, which makes them an attractive option for many patients.

Why Talk to Your Pharmacist?

Your pharmacist is an expert in medications and can provide valuable information about biosimilars. 

They can answer any questions you have about the safety, efficacy, and potential side effects of biosimilars, as well as whether they are an appropriate option for you. 

Pharmacists also work with your doctor to determine if a switch to a biosimilar is right for you and ensure a smooth transition.

How to Have a Productive Conversation

When talking to your pharmacist about biosimilars, it's important to come prepared with questions and be open to their answers. Some questions you may want to ask include:

• What is the difference between a brand-name biologic and a biosimilar?
• Are biosimilars just as safe and effective as brand-name biologics?
• Have any studies been conducted to compare the safety and efficacy of biosimilars to brand-name biologics?
• Will switching to a biosimilar affect the quality of my care?
• Will I experience any changes in my symptoms or side effects after switching to a biosimilar?
• Is there any additional information or resources you can provide to help me make an informed decision?

Your pharmacist may also have questions for you, such as your medical history and current medications, to help determine if a switch to a biosimilar is right for you.

Biosimilars offer a cost-effective alternative to brand-name biologics for Canadian patients. Talking to your pharmacist about biosimilars is an important step in making an informed decision about your healthcare. By asking questions and being open to their answers, you can ensure that you receive the best possible care.